PHNOM PENH, CAMBODIA—Scientists from the London School of Hygiene & Tropical Medicine are working along the Thai-Cambodian border: the ‘epicentre’ of resistance to artemisinin combination therapy — the newest, and so far most effective, treatment for malaria. Dr Shunmay Yeung talks about the importance of collecting scientific data rigorously to document what is happening — not only for the benefit of Cambodians but for the good of other countries facing similar threats.
You may also like...
Growing Evidence that Anti BRAF Melanoma Drugs Benefit Some Patients with Non-Small Cell Lung Cancer 27 Apr, 2015 Audio Journal of Global Health Issues: Good Adherence to HIV Antiretroviral Therapy in Rural Uganda 4 Dec, 2006 Complexity And Lack Of Independence — Hazards For Humanitarian Organisations Intervening In Disasters 21 Jun, 2011 Responses to enzalutamide after prior abiraterone therapy in men with castration-resistant metastatic prostate cancer 11 Feb, 2014
- Previous story Rio Conference on Sustainable Development: “Health Should Be Top Priority”
- Next story Pigs, birds, men: how disease might spread
- COVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
- Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
- First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
- Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
- Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014